Vanda Pharmaceuticals (VNDA) News Today
VNDA fell 10.69% in the 10 minutes after this headline crossed at 17:00:13 ET on Wednesday, Oct 14:
Vanda Pharmaceuticals pauses its social anxiety drug program after the experimental treatment misses the main goal in a late-stage study
Price 4.21 two minutes before the headline, 3.76 10 minutes after it.
Latest headline on this page:
Why Vanda Pharmaceuticals (VNDA) moved: the full explanation
1 headline on Vanda Pharmaceuticals appeared in our news feed in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was -10.69% over 10 minutes on VNDA, after the headline at Oct 14, 17:00:13 ET.
Price action when the news broke
17:00:13 ET
What moved VNDA — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Oct 14, 17:00:13 ET | Vanda Pharmaceuticals pauses its social anxiety drug program after the experimental treatment misses the main goal in a late-stage studyVolume 54.3K shares in 10 min | -16.86% | -10.69% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.
Our analysis
Why Vanda Pharmaceuticals (VNDA) Stock Fell 10.69% in 10 Minutes on Oct 14, 2026
Wednesday, Oct 14, 2026 · The 10.69% drop was larger than any reaction MoveSurge measured after Vanda Pharmaceuticals headlines between Jul 16, 2026 and Oct 13, 2026; the largest of those …
Why Was Vanda Pharmaceuticals (VNDA) Stock Up on Aug 24, 2026?
Monday, Aug 24, 2026 · The European Commission made it formal: the first orphan designation ever granted for generalized pustular psoriasis — five weeks after the committee opinion the wires blurred …